ATCG Holdings is a Fo Tan, Hong Kong-based life sciences company and strategic investor with China-linked later-stage venture exposure. Its investor relevance is strongest for biotechnology, oncology, pharmaceutical and medical-device opportunities, particularly where strategic life sciences distribution or market access in Hong Kong, Macau or China is relevant.